Marshall Wace North America’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-122,366
| Closed | -$20.2M | – | 1865 |
|
|
2021
Q2 | $20.2M | Sell |
122,366
-258,086
| -68% | -$43.1M | 0.08% | 254 |
|
|
2021
Q1 | $58.3M | Buy |
+380,452
| New | +$51.7M | 0.24% | 96 |
|
|
2020
Q1 | – | Sell |
-27,559
| Closed | -$3.06M | – | 1736 |
|
|
2019
Q4 | $3.06M | Buy |
27,559
+20,666
| +300% | +$2.13M | 0.01% | 482 |
|
|
2019
Q3 | $684K | Sell |
6,893
-42,304
| -86% | -$4.2M | ﹤0.01% | 759 |
|
|
2019
Q2 | $4.88M | Buy |
49,197
+5,778
| +13% | +$551K | 0.03% | 369 |
|
|
2019
Q1 | $4.79M | Buy |
+43,419
| New | +$4.54M | 0.03% | 331 |
|
|
2018
Q4 | – | Sell |
-2,148
| Closed | -$236K | – | 1711 |
|
|
2018
Q3 | $236K | Buy |
+2,148
| New | +$224K | ﹤0.01% | 825 |
|
|
2018
Q2 | – | Sell |
-318,888
| Closed | -$26.5M | – | 1842 |
|
|
2018
Q1 | $26.5M | Sell |
318,888
-270,584
| -46% | -$24M | 0.13% | 177 |
|
|
2017
Q4 | $53.7M | Buy |
589,472
+46,582
| +9% | +$3.87M | 0.3% | 76 |
|
|
2017
Q3 | $41.3M | Buy |
542,890
+162,882
| +43% | +$12.3M | 0.26% | 94 |
|
|
2017
Q2 | $28.5M | Sell |
380,008
-895,915
| -70% | -$62.1M | 0.21% | 122 |
|
|
2017
Q1 | $82.9M | Buy |
+1,275,923
| New | +$75.2M | 0.65% | 26 |
|
Other funds holding PRAH
Marshall Wace North America's PRAH Position: Q3 2021 in Review
Marshall Wace North America sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 122,366 shares — an estimated $20.2M sold.
Marshall Wace North America first reported a position in PRAH in Q1 2017 and held it in 12 quarters. The position peaked at $82.9M in Q1 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Marshall Wace North America reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Marshall Wace North America sold 122,366 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $20.2M.
- Marshall Wace North America first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 12 quarters.
- Marshall Wace North America's PRA Health Sciences, Inc. position peaked at $82.9M in Q1 2017.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.